Press releases
03/08/2023
H1 2023 revenue
05/07/2023
Results of the votes on the resolutions submitted to the Ordinary Annual Shareholders’ Meeting of 29 June 2023
09/06/2023
Annual Ordinary General Meeting – Meeting Notice and On-line availability of meeting materials
11/05/2023
Q1 2023 revenue: +13.96% to €56.25m
03/04/2023
Equasens Group’s Medical Solutions Division is reinforced by the addition of Pratilog and Speech2Sense
24/03/2023
2022 NET PROFIT: +18.35% TO €48.70M
03/02/2023
FY 2022 revenue: +10.88% to €214.07m
20/01/2023
H2 2022 Half-year report on the liquidity agreement with the brokerage firm Gilbert Dupont
19/01/2023
Appointment of Frédérique SCHMIDT as the Group’s Chief Administrative and Financial Officer
09/11/2022
2022 third-quarter revenue
18/10/2022
PANDALAB receives ISO 27001 and HDS certifications
22/09/2022
H1 2022 Results
03/08/2022
H1 2022 Revenue
28/07/2022
Equasens Group completes three majority acquisitions
21/07/2022
H1 2022 Half-year report on the liquidity agreement with the brokerage firm Gilbert Dupont
06/07/2022
Results of the votes on the resolutions submitted to the Ordinary Annual Shareholders’ Meeting of 28 June 2022
27/06/2022
EQUASENS joins Euronext’s new TECH LEADERS segment
15/06/2022
EQUASENS changes its ticker code to become EQS
10/06/2022
Annual Ordinary General Meeting – Meeting Notice and On-line availability of meeting materials
30/05/2022
Annual Ordinary General Meeting – Preliminary Notice
12/05/2022
Q1 2022 revenue: +9.03% to €49.36m
10/05/2022
